161 related articles for article (PubMed ID: 15745928)
1. Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency.
Sohmiya M; Kanazawa I; Kato Y
Eur J Endocrinol; 2005 Feb; 152(2):211-5. PubMed ID: 15745928
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency.
Sohmiya M; Kato Y
Clin Endocrinol (Oxf); 2001 Dec; 55(6):749-54. PubMed ID: 11895216
[TBL] [Abstract][Full Text] [Related]
3. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
6. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
[TBL] [Abstract][Full Text] [Related]
7. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
[TBL] [Abstract][Full Text] [Related]
8. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH;
Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.
Claessen KM; Appelman-Dijkstra NM; Adoptie DM; Roelfsema F; Smit JW; Biermasz NR; Pereira AM
J Clin Endocrinol Metab; 2013 Jan; 98(1):352-61. PubMed ID: 23162104
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of erythropoietin secretion by continuous subcutaneous infusion of recombinant human GH in anemic patients with chronic renal failure.
Sohmiya M; Ishikawa K; Kato Y
Eur J Endocrinol; 1998 Mar; 138(3):302-6. PubMed ID: 9539305
[TBL] [Abstract][Full Text] [Related]
12. Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism.
Bianchi A; Giampietro A; Tartaglione L; Chiloiro S; Gentilella R; Bima C; Anile C; Olivi A; Pontecorvi A; De Marinis L
J Neuroendocrinol; 2019 Apr; 31(4):e12692. PubMed ID: 30712287
[TBL] [Abstract][Full Text] [Related]
13. Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy.
Giavoli C; Porretti S; Ronchi CL; Cappiello V; Ferrante E; Orsi E; Arosio M; Beck-Peccoz P
Metabolism; 2004 Jun; 53(6):740-3. PubMed ID: 15164321
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of growth hormone therapy in malnourished hemodialysis patients.
Kotzmann H; Yilmaz N; Lercher P; Riedl M; Schmidt A; Schuster E; Kreuzer S; Geyer G; Frisch H; Hörl WH; Mayer G; Luger A
Kidney Int; 2001 Oct; 60(4):1578-85. PubMed ID: 11576376
[TBL] [Abstract][Full Text] [Related]
15. Effect of human recombinant growth hormone therapy on circulating levels of erythropoietin and granulocyte-colony stimulating factor in short children.
Meazza C; Bonomelli I; Pagani S; Travaglino P; Laarej K; Cantoni F; Bozzola M
J Pediatr Endocrinol Metab; 2009 Sep; 22(9):837-43. PubMed ID: 19960893
[TBL] [Abstract][Full Text] [Related]
16. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
[TBL] [Abstract][Full Text] [Related]
17. Administration of recombinant human growth hormone normalizes GH-IGF1 axis and improves malnutrition-related disorders in patients with anorexia nervosa.
Hashizume K; Suzuki S; Komatsu A; Hiramatsu K; Mori J; Yamazaki M; Takeda T; Kakizawa T; Miyamoto T; Koizumi Y; Ichikawa K
Endocr J; 2007 Apr; 54(2):319-27. PubMed ID: 17339748
[TBL] [Abstract][Full Text] [Related]
18. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
19. One-year growth hormone therapy improves granulocyte function without major effects on nutritional and anthropometric parameters in malnourished hemodialysis patients.
Kotzmann H; Schmidt A; Lercher P; Schuster E; Geyer G; Frisch H; Hörl WH; Mayer G; Luger A
Nephron Clin Pract; 2003; 93(2):C75-82. PubMed ID: 12616034
[TBL] [Abstract][Full Text] [Related]
20. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
